# American Realty Investors Inc: financial statements, quarterly

ARL · NYSE · CIK 1102238 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/arl.md) · [Financials](/companies/arl/financials.md) · [Filings](/companies/arl/filings.md) · [Insiders](/companies/arl/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/arl/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [12.5](/filings/0001102238-25-000004.md) | [14.0](/filings/0001102238-25-000004.md) | [11.9](/filings/0001628280-26-057878.md) | [11.8](/filings/0001628280-26-057878.md) | [11.6](/filings/0001628280-26-057878.md) | [12.0](/filings/0001628280-26-057878.md) | [12.0](/filings/0001628280-26-057878.md) | [12.2](/filings/0001628280-26-057878.md) | [12.8](/filings/0001628280-26-057878.md) | [13.0](/filings/0001628280-26-057878.md) | [12.3](/filings/0001628280-26-031837.md) | [12.9](/filings/0001628280-26-054101.md) |
| Operating income | $m | [(2.1)](/filings/0001102238-25-000004.md) | [(2.2)](/filings/0001102238-25-000004.md) | [(1.5)](/filings/0001628280-26-057878.md) | [(1.3)](/filings/0001628280-26-057878.md) | [(2.1)](/filings/0001628280-26-057878.md) | [(1.8)](/filings/0001628280-26-057878.md) | [(0.8)](/filings/0001628280-26-057878.md) | [(1.0)](/filings/0001628280-26-057878.md) | [(1.6)](/filings/0001628280-26-057878.md) | [(3.0)](/filings/0001628280-26-057878.md) | [(2.2)](/filings/0001628280-26-031837.md) | [(2.5)](/filings/0001628280-26-054101.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [1.1](/filings/0001102238-24-000025.md) | [(1.0) d](/filings/0001628280-26-057878.md) | [0.5](/filings/0001102238-25-000012.md) | [0.6](/filings/0001102238-25-000017.md) | [(4.6)](/filings/0001102238-25-000027.md) | [(0.1) d](/filings/0001628280-26-057878.md) | [1.1](/filings/0001628280-26-031837.md) | [(1.3)](/filings/0001628280-26-054101.md) | [1.4](/filings/0001102238-25-000027.md) | [1.5 d](/filings/0001628280-26-057878.md) | [(0.4)](/filings/0001628280-26-031837.md) | [(0.1)](/filings/0001628280-26-054101.md) |
| Net income | $m | [3.0](/filings/0001102238-25-000004.md) | [(2.1)](/filings/0001102238-25-000004.md) | [1.8](/filings/0001628280-26-057878.md) | [1.2](/filings/0001628280-26-057878.md) | [(17.5)](/filings/0001628280-26-057878.md) | [(0.2)](/filings/0001628280-26-057878.md) | [3.0](/filings/0001628280-26-057878.md) | [2.8](/filings/0001628280-26-057878.md) | [0.1](/filings/0001628280-26-057878.md) | [9.8](/filings/0001628280-26-057878.md) | [(0.6)](/filings/0001628280-26-031837.md) | [(1.0)](/filings/0001628280-26-054101.md) |
| Diluted EPS | $ per share | [0.18](/filings/0001102238-25-000004.md) | [(0.13)](/filings/0001102238-25-000004.md) | [0.11](/filings/0001628280-26-057878.md) | [0.07](/filings/0001628280-26-057878.md) | [(1.08)](/filings/0001628280-26-057878.md) | [(0.01)](/filings/0001628280-26-057878.md) | [0.18](/filings/0001628280-26-057878.md) | [0.18](/filings/0001628280-26-057878.md) | [0.01](/filings/0001628280-26-057878.md) | [0.60](/filings/0001628280-26-057878.md) | [(0.03)](/filings/0001628280-26-031837.md) | [(0.06)](/filings/0001628280-26-054101.md) |
| Basic EPS | $ per share | [0.18](/filings/0001102238-25-000004.md) | [(0.13)](/filings/0001102238-25-000004.md) | [0.11](/filings/0001628280-26-057878.md) | [0.07](/filings/0001628280-26-057878.md) | [(1.08)](/filings/0001628280-26-057878.md) | [(0.01)](/filings/0001628280-26-057878.md) | [0.18](/filings/0001628280-26-057878.md) | [0.18](/filings/0001628280-26-057878.md) | [0.01](/filings/0001628280-26-057878.md) | [0.60](/filings/0001628280-26-057878.md) | [(0.03)](/filings/0001628280-26-031837.md) | [(0.06)](/filings/0001628280-26-054101.md) |

- Revenue: us-gaap:Revenues
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [47.2](/filings/0001102238-24-000025.md) | [36.7](/filings/0001628280-26-057878.md) | [54.7](/filings/0001102238-25-000012.md) | [46.1](/filings/0001102238-25-000017.md) | [39.5](/filings/0001102238-25-000027.md) | [19.9](/filings/0001628280-26-057878.md) | [13.8](/filings/0001102238-25-000012.md) | [15.5](/filings/0001102238-25-000017.md) | [12.0](/filings/0001102238-25-000027.md) | [14.2](/filings/0001628280-26-057878.md) | [9.6](/filings/0001628280-26-031837.md) | [10.8](/filings/0001628280-26-054101.md) |
| Total assets | $m | [1,062](/filings/0001102238-23-000023.md) | [1,023](/filings/0001102238-25-000004.md) | [1,022](/filings/0001102238-24-000012.md) | [1,026](/filings/0001102238-24-000017.md) | [1,043](/filings/0001102238-24-000025.md) | [1,033](/filings/0001628280-26-057878.md) | [1,045](/filings/0001102238-25-000012.md) | [1,086](/filings/0001102238-25-000017.md) | [1,096](/filings/0001102238-25-000027.md) | [1,097](/filings/0001628280-26-057878.md) | [1,089](/filings/0001628280-26-031837.md) | [1,090](/filings/0001628280-26-054101.md) |
| Total liabilities | $m | [242](/filings/0001102238-23-000023.md) | [207](/filings/0001102238-25-000004.md) | [204](/filings/0001102238-24-000012.md) | [207](/filings/0001102238-24-000017.md) | [240](/filings/0001102238-24-000025.md) | [231](/filings/0001628280-26-057878.md) | [239](/filings/0001102238-25-000012.md) | [278](/filings/0001102238-25-000017.md) | [288](/filings/0001102238-25-000027.md) | [278](/filings/0001628280-26-057878.md) | [274](/filings/0001628280-26-031837.md) | [276](/filings/0001628280-26-054101.md) |
| Long-term debt | $m | [182](/filings/0001102238-23-000023.md) | [183](/filings/0001102238-25-000004.md) | [182](/filings/0001102238-24-000012.md) | [181](/filings/0001102238-24-000017.md) | [184](/filings/0001102238-24-000025.md) | [185](/filings/0001628280-26-057878.md) | [202](/filings/0001102238-25-000012.md) | [216](/filings/0001102238-25-000017.md) | [227](/filings/0001102238-25-000027.md) | [214](/filings/0001628280-26-057878.md) | [215](/filings/0001628280-26-031837.md) | [218](/filings/0001628280-26-054101.md) |
| Shareholders' equity | $m | [620](/filings/0001102238-23-000023.md) | [617](/filings/0001102238-25-000004.md) | [619](/filings/0001102238-24-000012.md) | [620](/filings/0001102238-24-000017.md) | [602](/filings/0001102238-24-000025.md) | [602](/filings/0001628280-26-057878.md) | [605](/filings/0001102238-25-000012.md) | [608](/filings/0001102238-25-000017.md) | [608](/filings/0001102238-25-000027.md) | [617](/filings/0001628280-26-057878.md) | [620](/filings/0001628280-26-031837.md) | [619](/filings/0001628280-26-054101.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [16.3 d](/filings/0001102238-24-000025.md) | [(38.9) d](/filings/0001628280-26-057878.md) | [3.9](/filings/0001102238-25-000012.md) | [(0.5) d](/filings/0001102238-25-000017.md) | [13.5 d](/filings/0001102238-25-000027.md) | [(15.8) d](/filings/0001628280-26-057878.md) | [(7.4)](/filings/0001628280-26-031837.md) | [(2.9) d](/filings/0001628280-26-054101.md) | [8.0 d](/filings/0001102238-25-000027.md) | [(3.2) d](/filings/0001628280-26-057878.md) | [0.9](/filings/0001628280-26-031837.md) | [(2.4) d](/filings/0001628280-26-054101.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [16.2](/filings/0001102238-23-000023.md) | [16.2](/filings/0001102238-24-000012.md) | [16.2](/filings/0001102238-24-000017.md) | [16.2](/filings/0001102238-24-000025.md) | [16.2](/filings/0001102238-25-000012.md) | [16.2](/filings/0001102238-25-000017.md) | [16.2](/filings/0001102238-25-000027.md) | [16.2](/filings/0001628280-26-031837.md) | [16.2](/filings/0001628280-26-054101.md) | [16.2](/filings/0001102238-25-000027.md) | [16.2](/filings/0001628280-26-031837.md) | [16.2](/filings/0001628280-26-054101.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 16,152,043 at 2026-08-06, from the cover of the [10-Q filed 2026-08-06](/filings/0001628280-26-054101.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:33 ET. No prices; not investment advice.